DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 07 · Volume 64 · 1990 DOI: 10.1055/s-008-40439

Review Article

  • 344
    Märki, Walter E; Wallis, Robert B:

    The Anticoagulant and Antithrombotic Properties of Hirudins

    • Original Article

  • 349
    Rodeghiero, Francesco; Castaman, Giancarlo; Tosetto, Alberto:

    Von Willebrand Factor Antigen Is Less Sensitive than Ristocetin Cofactor for the Diagnosis of Type I von Willebrand Disease -Results Based on an Epidemiological Investigation

  • 353
    Solano, C; Cobcroft, R G; Scott, D C:

    Prediction of Vitamin K Response Using the Echis Time and Echis-Prothrombin Time Ratio

  • 358
    Cattaneo, Marco; Tenconi, Paola M; Alberca, Ignazio; Garcia, Vicente Vicente; Mannucci, Pier Mannuccio:

    Subcutaneous Desmopressin (DDAVP) Shortens the Prolonged Bleeding Time in Patients with Liver Cirrhosis

  • 361
    Nanninga, P B; van Teunenbroek, A; Veenhof, C H N; Büller, H R; ten Cate, J W:

    Low Prevalence of Coagulation and Fibrinolytic Activation in Patients with Primary Untreated Cancer

  • 365
    Toulon, P; Bardin, J M; Blumenfeld, N M:

    Increased Heparin Cofactor II Levels in Women Taking Oral Contraceptives

  • 369
    Lane, I F; Lumley, P; Michael, M F; Peters, A M; McCollum, C N:

    A Specific Thromboxane Receptor Blocking Drug, AH23848, Reduces Platelet Deposition on Vascular Grafts in Man

  • 374
    Farrugia, A; Douglas, S; James, J; Whyte, G; Herrington, R:

    Use of Plasma with High Levels of lonised Calcium in the Production of Model Scale Goagulation Factor Concentrates

  • 379
    Poort, S R; Briët, E; Bertina, R M; Reitsma, P H:

    Two Mutations of the Factor IX Gene Including a Donor Splice Consensus Deletion and a Point Mutation in a Dutch Patient with Severe Hemophilia B

  • 385
    Hansen, John-Bjarne; Wilsgård, Line; Olsen, Jan Ole; Østerud, Bjarne:

    Formation and Persistence of Procoagulant and Fibrinolytic Activities in Circulation after Strenuous Physical Exercise

  • 390
    Binnema, D J; Dooijewaard, G; van Iersel, J J L; Turion, P N C; Kluft, C:

    The Contact-System Dependent Plasminogen Activator from Human Plasma: Identification and Characterization

  • 398
    Gaffney, P J; Heath, A B:

    A Collaborative Study to Establish a Standard for High Molecular Weight Urinary-Type Plasminogen Activator (HMW/u-PA)

  • 402
    Oethinger, M D; Seifried, E:

    In Vitro Effects of Urokinase — Prevention by Different Inhibitors

  • 407
    George, F; Pourreau-Schneider, N; Boutiere, B; Arnoux, D; Boutiére, B; Berthois, Y; Martin, P M; Sampol, J:

    Concomitant Secretion by A431 Cells of Tissue Plasminogen Activator and a Specific Inhibitor Masks EGF Modulation of tPA Activity

  • 412
    Fujii, Satoshi; Lucore, Charles L; Hopkins, William E; Billadello, Joseph J; Sobel, Burton E:

    Induction of Synthesis of Plasminogen Activator Inhibitor Type-1 byTissue-Type Plasminogen Activator in Human Hepatic and Endothelial Cells

  • 420
    Grulich-Henn, Jürgen; Preissner, Klaus T; Müller-Berghaus, Gert:

    Heparin Stimulates Fibrinolysis in Mesothelial Cells by Selective lnduction of Tissue-Plasminogen Activator but not Plasminogen Activator Inhibitor-l Synthesis

  • 426
    Abercrombie, David M; Buchinski, Bruce; Salvato, Kathleen A; Vovis, Gerald F; Stump, David C; Broeze, Robert J:

    Fibrin Specific Thrombolysis by Two-Chain Urokinase-Type Plasminogen Activator Cleaved after Arginine 156 by Thrombin

  • 433
    Keber, D; Blinc, A; Fettich, J:

    lncrease of Tissue Plasminogen Activator in Limbs During Venous Occlusion : A Simple Haemodynamic Model

  • 438
    Voytik, Sherry; Badylak, Stephen F; Burke, Sandra; Klabunde, Richard E; Henkin, Jack; Simmons, Abby:

    The Protective Effect of Heparin in a Dog Model of Rethrombosis Following Pharmacologic Thrombolysis

  • 445
    Senatore, F; Shankar, H; Ho, C H; Avantsa, S; Allon, M; Posteraro, R:

    Effect of Soluble and Immobilized Plasmin on Fibrinogen and Platelets

  • 450
    Sabovic, M; Lijnen, H R; Keber, D; Collen, D:

    Correlation between Progressive Adsorption of Plasminogen to Blood Clots and Their Sensitivity to Lysis

  • 455
    Jones, A J S; Meunier, A M:

    A Precise and Rapid Microtitre Plate Clot Lysis Assay: Methodology, Kinetic Modeling and Measurement of Catalytic Constants for Plasminogen Activation during Fibrinolysis

  • 464
    Lindhout, Theo; Blezer, Ron; Coenraad Hemker, H:

    The Anticoagulant Mechanism of Action of Recombinant Hirudin (CGP 39393) in Plasma

  • 469
    Stenziger, Werner; Kehrel, Beate; van de Loo, Jürgen:

    Identification of Platelet Antigens by Immunoprecipitation of Unlabelled Platelet Glycoproteins

  • 473
    Chen, Shih-Luen; Yang, Wu-Chang; Huang, Tung-Po; Wann, Shiang; Teng, Che-ming:

    Chlorobutanol, a Preservative of Desmopressin, Inhibits Human Platelet Aggregation and Release In Vitro

    • Scientific and Standardization Committee Communications

  • 478
    Exner, Thomas; Triplett, Douglas A; Taberner, David A; Howard, Margaret A; Harris, E Nigel:

    Scientific and Standardization Committee Communications Comparison of Test Methods for the Lupus Anticoagulant: International Survey on Lupus Anticoagulants-I (ISLA-1)

    • Letter to the Editor

  • 485
    Grodzinska, Lilia; Hafner, Gerd; Darius, Harald; Medizinische Klinik, II:

    Effest of Molsidomine on t-PA and PAI Activity in Man: A Double Blind, Placebo Controlled Study

  • 486
    O’Brien, J R; Ethwrington, M D:

    How Much Aspirin?

  • 487
    Maschio, Aldo Del; Bazzoni, Gianfranco; Bertelá, Vittorio:

    Investigation of Platelet/Leukocyte Interaction by Whole Blood Aggregometry

  • 488
    Lionnet, F; Gouault-Heilmann, M; Azoulay, C; Lacorte, J M; Schaeffer, A:

    Auto-lmmune Eactor Vlll : G lnhibitor Durably Responsive to lmmunoglobulin: A New Case

  • 490
    Dautzenberg, M D; Bara, L; Cornu, P; Samama, M:

    Specific Anti-Xa Activity of LMWH (Kabi 2165, CY216 PK 10169) Against the First International Standard of LMWH: A Collaborative Study